Circulating miR-16 as an Early Biomarker of Subclinical Myocardial Strain Impairment in Pediatric Primary Hypertension
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27062806 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Michał Szyszka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Nephrology, Doctoral School, Medical University of Warsaw, 02-091 Warsaw, Poland. Hauptthemen laut MEDLINE: MicroRNAs, Hypertension, Essential Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, National Science Centre, Poland.
Abstract (Originalsprache)
The role of circulating microRNAs in the pathophysiology of cardiac remodeling in primary hypertension (PH) remains incompletely understood. Left ventricular global longitudinal strain (LV GLS) is a sensitive marker of subclinical systolic dysfunction and can be used to monitor early cardiac involvement in cardiovascular and renal diseases. To the best of our knowledge, this is the first study to demonstrate an association between circulating miR-16 and LV GLS in children. The study aimed to evaluate the expression levels of miR-16-5p, -21-5p, -27a-3p, -27b-3p, -133a-3p, and -145-5p in untreated children with PH and examine their associations with LV GLS. 50 children with PH and 57 normotensive controls were evaluated for circulating microRNA expression levels and echocardiographic parameters, including LV GLS. Comprehensive anthropometric, biochemical, blood pressure, and arterial indices were also assessed. Among the analyzed microRNAs, miR-16-5p exhibited a positive association with LV GLS (R = 0.305, p = 0.031), whereas miR-27b-3p demonstrated a negative association (R = −0.330, p < 0.001). Compared with controls, hypertensive children exhibited significantly higher (i.e., less negative) LV GLS (r = 0.29, p = 0.002), indicating early systolic dysfunction occurring already at an early stage of the disease. In conclusion, these findings support the idea that specific microRNAs might play a differential role in early myocardial functional alterations in pediatric PH. Higher miR-16 expression levels may be associated with impaired myocardial deformation, potentially reflecting its involvement in early maladaptive myocardial remodeling. Furthermore, LV GLS may represent a sensitive and clinically informative marker of early myocardial dysfunction beyond traditional echocardiographic parameters in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics and Nephrology, Doctoral School, Medical University of Warsaw, 02-091 Warsaw, Poland.
- Department of Pediatric Cardiology and General Pediatrics, Medical University of Warsaw, 02-091 Warsaw, Poland.
- Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Pediatric Hospital of Medical University of Warsaw; 02-091 Warsaw, Poland.
- Laboratory of Genetics, University Center for Laboratory Medicine, University Clinical Centre of the Medical University of Warsaw, 02-091 Warsaw, Poland.
- Department of Experimental and Clinical Pharmacology, Center for Preclinical Research and Technology CEPT, Medical University of Warsaw, 02-091 Warsaw, Poland.
- Genomics Core Facility, Centre of New Technologies, University of Warsaw, 02-097 Warsaw, Poland.
ORCID-Profile: Michał Szyszka, Radosław Pietrzak, Piotr Skrzypczyk
Förderung
- National Science Centre
- National Science Centre, Poland
Zitieren
APA
Szyszka, M., Pietrzak, R., Obsznajczyk, K., Skubisz, K., Eyileten, C., & Skrzypczyk, P. (2026). Circulating miR-16 as an Early Biomarker of Subclinical Myocardial Strain Impairment in Pediatric Primary Hypertension. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27062806
Vancouver
Szyszka M, Pietrzak R, Obsznajczyk K, Skubisz K, Eyileten C, Skrzypczyk P. Circulating miR-16 as an Early Biomarker of Subclinical Myocardial Strain Impairment in Pediatric Primary Hypertension. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27062806
BibTeX
@article{Szyszka2026,
author = {Szyszka, Michał and Pietrzak, Radosław and Obsznajczyk, Klaudia and Skubisz, Karolina and Eyileten, Ceren and Skrzypczyk, Piotr},
title = {Circulating miR-16 as an Early Biomarker of Subclinical Myocardial Strain Impairment in Pediatric Primary Hypertension},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27062806}
}
EUVIMED